An interventional study of intensive rehabilitation program in Chronic Non-specific Low Back Pain, sponsored by Hasselt University. Completed at 1 site in Belgium. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2017-08-09.
Sponsored by Hasselt University · Not applicable, Interventional, and Other
This clinical pilot trial will investigate the effects of technology-supported exercise therapy for chronic non-specific low back pain. Patients will follow an intensive rehabilitation program (2x/week for 18 weeks), with emphasis on motor control training that is supported by technology. The technological system consists out of motion tracking sensors that register the movements and position of the lumbar spine.
2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.
This study's planned enrollment of 10 is below the median of 60 across 1,941 interventional studies indexed under Back Pain.
Browse Back Pain studies →Hasselt University is the lead sponsor of 195 studies on the registry; 30 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients will follow an intensive rehabilitation program (2x/week for 18 weeks), with emphasis on motor control training that is supported by technology.
Other: intensive rehabilitation program
Patients will follow an intensive rehabilitation program (2x/week for 18 weeks), with emphasis on motor control training that is supported by technology. The technological system consists out of motion tracking sensors that register the movements and position of the lumbar spine.
The numeric pain rating scale
the numeric pain rating scale (0-10)
Time frame: baseline
The numeric pain rating scale
the numeric pain rating scale (0-10)
Time frame: week 3
The numeric pain rating scale
the numeric pain rating scale (0-10)months post-intervention.
Time frame: week 8
The numeric pain rating scale
the numeric pain rating scale (0-10)
Time frame: week 13
The numeric pain rating scale
the numeric pain rating scale (0-10)
Time frame: week 18
The numeric pain rating scale
the numeric pain rating scale (0-10)
Time frame: week 44
Roland Morris Questionnaire (0-24)
Roland Morris Questionnaire (0-24)
Time frame: baseline
Roland Morris Questionnaire (0-24)
Roland Morris Questionnaire (0-24)
Time frame: week 3
Roland Morris Questionnaire (0-24)
Roland Morris Questionnaire (0-24)
Time frame: week 8
Roland Morris Questionnaire (0-24)
Roland Morris Questionnaire (0-24)
Time frame: week 13
Roland Morris Questionnaire (0-24)
Roland Morris Questionnaire (0-24)
Time frame: week 18
Roland Morris Questionnaire (0-24)
Roland Morris Questionnaire (0-24)
Time frame: week 44
Patient specific functioning scale (0-10)
Patient specific functioning scale (0-10)
Time frame: baseline
Patient specific functioning scale (0-10)
Patient specific functioning scale (0-10)
Time frame: week 3
Patient specific functioning scale (0-10)
Patient specific functioning scale (0-10)
Time frame: week 8
Patient specific functioning scale (0-10)
Patient specific functioning scale (0-10)
Time frame: week 13
Patient specific functioning scale (0-10)
Patient specific functioning scale (0-10)
Time frame: week 18
Patient specific functioning scale (0-10)
Patient specific functioning scale (0-10)
Time frame: week 44
Pain self-efficacy questionnaire (0-60)
Pain self-efficacy questionnaire (0-60)
Time frame: baseline
Pain self-efficacy questionnaire (0-60)
Pain self-efficacy questionnaire (0-60)
Time frame: week 3
Pain self-efficacy questionnaire (0-60)
Pain self-efficacy questionnaire (0-60)
Time frame: week 8
Pain self-efficacy questionnaire (0-60)
Pain self-efficacy questionnaire (0-60)
Time frame: week 13
Pain self-efficacy questionnaire (0-60)
Pain self-efficacy questionnaire (0-60)
Time frame: week 18
Pain self-efficacy questionnaire (0-60)
Pain self-efficacy questionnaire (0-60)
Time frame: week 44
the Tampa scale for kinesiophobia (17-68)
the Tampa scale for kinesiophobia (17-68)
Time frame: baseline
the Tampa scale for kinesiophobia (17-68)
the Tampa scale for kinesiophobia (17-68)
Time frame: week 3
the Tampa scale for kinesiophobia (17-68)
the Tampa scale for kinesiophobia (17-68)
Time frame: week 8
the Tampa scale for kinesiophobia (17-68)
the Tampa scale for kinesiophobia (17-68)
Time frame: week 13
the Tampa scale for kinesiophobia (17-68)
the Tampa scale for kinesiophobia (17-68)
Time frame: week 18
the Tampa scale for kinesiophobia (17-68)
the Tampa scale for kinesiophobia (17-68)
Time frame: week 44
Patient satisfaction with treatment (0-10)
Patient satisfaction with treatment (0-10)
Time frame: baseline
Patient satisfaction with treatment (0-10)
Patient satisfaction with treatment (0-10)
Time frame: week 3
Patient satisfaction with treatment (0-10)
Patient satisfaction with treatment (0-10)
Time frame: week 8
Patient satisfaction with treatment (0-10)
Patient satisfaction with treatment (0-10)
Time frame: week 13
Patient satisfaction with treatment (0-10)
Patient satisfaction with treatment (0-10)
Time frame: week 18
Patient satisfaction with treatment (0-10)
Patient satisfaction with treatment (0-10)
Time frame: week 44
short form 36
Quality of life, SF-36 questionnaire
Time frame: baseline
short form 36
Quality of life, SF-36 questionnaire
Time frame: week 3
short form 36
Quality of life, SF-36 questionnaire
Time frame: week 8
short form 36
Quality of life, SF-36 questionnaire
Time frame: week 13
short form 36
Quality of life, SF-36 questionnaire
Time frame: week 18
short form 36
Quality of life, SF-36 questionnaire
Time frame: week 44
Credibility and expectancy questionnaire
Credibility and expectancy questionnaire
Time frame: baseline
Credibility and expectancy questionnaire
Credibility and expectancy questionnaire
Time frame: week 3
Credibility and expectancy questionnaire
Credibility and expectancy questionnaire
Time frame: week 8
Credibility and expectancy questionnaire
Credibility and expectancy questionnaire
Time frame: week 13
Credibility and expectancy questionnaire
Credibility and expectancy questionnaire
Time frame: week 18
Credibility and expectancy questionnaire
Credibility and expectancy questionnaire
Time frame: week 44
Intrinsic motivation inventory form
Intrinsic motivation inventory form
Time frame: baseline
Intrinsic motivation inventory form
Intrinsic motivation inventory form
Time frame: week 3
Intrinsic motivation inventory form
Intrinsic motivation inventory form
Time frame: week 8
Intrinsic motivation inventory form
Intrinsic motivation inventory form
Time frame: week 13
Intrinsic motivation inventory form
Intrinsic motivation inventory form
Time frame: week 18
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Time frame: baseline
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Time frame: week 3
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Time frame: week 8
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Time frame: week 13
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Time frame: week 18
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Time frame: week 44
Adherence to exercise program assessed by number of visits attended and self-reported adherence to home exercises
Adherence to exercise program (number of visits attended, self-reported adherence to home exercises)
Time frame: baseline
Adherence to exercise program assessed by number of visits attended and self-reported adherence to home exercises
Adherence to exercise program (number of visits attended, self-reported adherence to home exercises)
Time frame: week 3
Adherence to exercise program assessed by number of visits attended and self-reported adherence to home exercises
Adherence to exercise program (number of visits attended, self-reported adherence to home exercises)
Time frame: week 8
Adherence to exercise program assessed by number of visits attended and self-reported adherence to home exercises
Adherence to exercise program (number of visits attended, self-reported adherence to home exercises)
Time frame: week 13
Adherence to exercise program assessed by number of visits attended and self-reported adherence to home exercises
Adherence to exercise program (number of visits attended, self-reported adherence to home exercises)
Time frame: week18
This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hasselt University